US drugmaker Eli Lilly has announced plans to invest $2.1 billion to expand its manufacturing footprint by setting up two new sites in Boone County, Indiana. The...
Bachem, a Swiss specialist in the development manufacture and manufacture of peptides and oligonucleotides, has entered into a strategic collaboration with major...
What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...
US drugmaker Eli Lilly is investing about $700 million to establish an institute for researching and developing genetic medicines at a new site in the Seaport area of...
Lilly has announced plans to spend more than $1.5 billion on new manufacturing facilities in the US and Ireland, as it beefs up its global network to meet rising demand...
Loxo Oncology at Lilly and Foghorn Therapeutics are collaborating to create novel oncology medicines based on the latter’s Gene Traffic Control platform. Under the terms...
US drugmaker Eli Lilly has announced changes to its executive leadership team as it creates two new business units in order to strengthen its focus on introducing...
US drugmaker Eli Lilly has acquired Protomer Technologies, strengthening its diabetes portfolio. The deal gives Lilly full control over the privately held US biotech...
